Siemens Healthineers to Equip Braunschweig Municipal Hospital's Central Laboratory

Siemens HealthineersSiemens Healthineers and Braunschweig Municipal Hospital signed a 10-year contract for a new diagnostics and analysis center at the hospital. As general contractor, Siemens Healthineers will supply all the medical technology for a the new, highly automated interdisciplinary center and operate it across manufacturers. The contract is worth around 80 million euros. Siemens Healthineers will involve partner companies in the technical equipment for special laboratory areas.

From mid-2025, the new central laboratory will further improve patient care in the community, accelerate therapy processes and patient recovery, and make service provision more efficient. The order includes the supply of approximately 300 laboratory devices, including the Atellica Solution and the Atellica CI Analyzer for faster turnaround times. In addition to technical management, the contract also provides for the supply of IT infrastructure and consumables. In the future, the highly automated facility will cover many laboratory areas with well over 1,000 different test methods and analysis options - from clinical chemistry, hemostasis, microbiology, molecular diagnostics and transfusion medicine to digital pathology.

"With the construction of the new interdisciplinary diagnostics and analysis center, we are bundling our expertise in the region and making efficient use of specialists and technology," said Dr. Andreas Goepfert, managing director of Städitsches Klinikum Braunschweig gGmbH.

Dr. Raimar Goldschmidt, managing director of skbs.digital GmbH., said: "The cooperation with Siemens Healthineers ensures that the hospital will provide laboratory medical services at the highest technical level - while at the same time operating the equipment by our experienced, highly qualified laboratory staff."

With this partnership, Siemens Healthineers will become the technology partner and operator for the essential technical diagnostics of the Braunschweig hospital in the future - from ultrasound to X-ray and radiation therapy to laboratory diagnostics. In a modern hospital, laboratory diagnostics determine more than 70 percent of therapeutic decisions.

"We are proud and grateful for the trust placed in us," said Dr. Guido Schütte, head of laboratory diagnostics Germany and the Netherlands at Siemens Healthineers. "From our point of view, this project is a prime example of the modern, efficient operational organisation of municipal hospitals. The medical expertise will remain in the hospital, while the equipment will be supported by an experienced industrial partner. This will allow the hospital to concentrate even better on its core competency of patient care."

The new interdisciplinary diagnostics and analysis center in Braunschweig will also be able to provide other interested hospitals in the region with access to state-of-the-art diagnostics, enabling the, personnel and state-of-the-art technology to be used to their full potential. The possibility of cooperation will also become more important in view of the shortage of skilled workers. Hospital Wolfsburg will become a corporate partner and hospital Wolfenbüttel has also signaled its intention to become a customer of the innovative services.

About Siemens Healthineers

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies are continuously developing their product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company's foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers' ability to provide high-quality, efficient care. In fiscal 2022, which ended on September 30, 2022, Siemens Healthineers, which has approximately 69,500 employees worldwide, generated revenue of around €21.7 billion and adjusted EBIT of almost €3.7 billion.

About Braunschweig Municipal Hospital

With 1,475 fully inpatient beds and 24 day-care beds and 4,274 hospital employees (almost 5,000 including subsidiaries), Klinikum Braunschweig is one of the largest employers in the region. As a maximum care hospital at university level, it serves the Braunschweig region with around 1.2 million inhabitants. With 21 clinics, 10 independent clinical departments and 7 institutes, almost the entire spectrum of medical subjects is covered. Every year, more than 50,000 inpatients and around 200,000 outpatients are treated. Three locations belong to the Municipal Hospital: Klinikum Holwedestraße, Klinikum Salzdahlumer Straße, Klinikum Celler Straße and the Outpatient Rehabilitation Centre in Nîmes Straße. The hospital has a turnover of around 360 million euros per year. As a major client for construction and maintenance measures, investments in equipment and IT as well as other services, it awards contracts worth more than 80 million euros per year. For more information, see www.skbs.de

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...